173 related articles for article (PubMed ID: 16579639)
1. Increased intracellular targeting to airway cells using octaarginine-coated liposomes: in vitro assessment of their suitability for inhalation.
Cryan SA; Devocelle M; Moran PJ; Hickey AJ; Kelly JG
Mol Pharm; 2006; 3(2):104-12. PubMed ID: 16579639
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model.
Abu Lila AS; Kizuki S; Doi Y; Suzuki T; Ishida T; Kiwada H
J Control Release; 2009 Jul; 137(1):8-14. PubMed ID: 19285528
[TBL] [Abstract][Full Text] [Related]
3. Immunoprotection against murine bladder carcinoma by octaarginine-modified liposomes incorporating cell wall of Mycobacterium bovis bacillus Calmette-Guérin.
Joraku A; Homhuan A; Kawai K; Yamamoto T; Miyazaki J; Kogure K; Yano I; Harashima H; Akaza H
BJU Int; 2009 Mar; 103(5):686-93. PubMed ID: 19040525
[TBL] [Abstract][Full Text] [Related]
4. Pentapeptide YIGSR-mediated HT-1080 fibrosarcoma cells targeting of adriamycin encapsulated in sterically stabilized liposomes.
Lopez-Barcons LA; Polo D; Reig F; Fabra A
J Biomed Mater Res A; 2004 Apr; 69(1):155-63. PubMed ID: 14999763
[TBL] [Abstract][Full Text] [Related]
5. Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking.
Khalil IA; Kogure K; Futaki S; Harashima H
Int J Pharm; 2008 Apr; 354(1-2):39-48. PubMed ID: 18242018
[TBL] [Abstract][Full Text] [Related]
6. Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation.
Jaafar-Maalej C; Diab R; Andrieu V; Elaissari A; Fessi H
J Liposome Res; 2010 Sep; 20(3):228-43. PubMed ID: 19899957
[TBL] [Abstract][Full Text] [Related]
7. A new liposome-based gene delivery system targeting lung epithelial cells using endothelin antagonist.
Allon N; Saxena A; Chambers C; Doctor BP
J Control Release; 2012 Jun; 160(2):217-24. PubMed ID: 22079949
[TBL] [Abstract][Full Text] [Related]
8. In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer.
Anabousi S; Bakowsky U; Schneider M; Huwer H; Lehr CM; Ehrhardt C
Eur J Pharm Sci; 2006 Dec; 29(5):367-74. PubMed ID: 16952451
[TBL] [Abstract][Full Text] [Related]
9. TAT-peptide modified liposomes: preparation, characterization, and cellular interaction.
Fretz MM; Storm G
Methods Mol Biol; 2010; 605():349-59. PubMed ID: 20072893
[TBL] [Abstract][Full Text] [Related]
10. Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD.
Watkins CL; Brennan P; Fegan C; Takayama K; Nakase I; Futaki S; Jones AT
J Control Release; 2009 Dec; 140(3):237-44. PubMed ID: 19409429
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-coated liposomes for delivery to lungs by nebulisation.
Zaru M; Manca ML; Fadda AM; Antimisiaris SG
Colloids Surf B Biointerfaces; 2009 Jun; 71(1):88-95. PubMed ID: 19201583
[TBL] [Abstract][Full Text] [Related]
12. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
Demirgöz D; Garg A; Kokkoli E
Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
14. A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells.
Mai J; Song S; Rui M; Liu D; Ding Q; Peng J; Xu Y
J Control Release; 2009 Nov; 139(3):174-81. PubMed ID: 19576253
[TBL] [Abstract][Full Text] [Related]
15. Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells.
Kobayashi T; Ishida T; Okada Y; Ise S; Harashima H; Kiwada H
Int J Pharm; 2007 Feb; 329(1-2):94-102. PubMed ID: 16997518
[TBL] [Abstract][Full Text] [Related]
16. A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway.
Mudhakir D; Akita H; Tan E; Harashima H
J Control Release; 2008 Jan; 125(2):164-73. PubMed ID: 18054812
[TBL] [Abstract][Full Text] [Related]
17. Intracellular delivery enhancement of poly(amino acid) drug carriers by oligoarginine conjugation.
Yang SR; Kim SB; Joe CO; Kim JD
J Biomed Mater Res A; 2008 Jul; 86(1):137-48. PubMed ID: 17957717
[TBL] [Abstract][Full Text] [Related]
18. Increased stability in plasma and enhanced cellular uptake of thermally denatured albumin-coated liposomes.
Jung SH; Kim SK; Jung SH; Kim EH; Cho SH; Jeong KS; Seong H; Shin BC
Colloids Surf B Biointerfaces; 2010 Apr; 76(2):434-40. PubMed ID: 20036109
[TBL] [Abstract][Full Text] [Related]
19. Efficiency of cytoplasmic delivery by non-cationic liposomes to cells in vitro: a confocal laser scanning microscopy study.
Mady MM; Ghannam MM; Khalil WA; Müller R; Fahr A
Phys Med; 2009 Jun; 25(2):88-93. PubMed ID: 18590977
[TBL] [Abstract][Full Text] [Related]
20. Liposome-based intracellular kinetics of doxorubicin in K562/DOX cells.
Xu DH; Gao JQ; Liang WQ
Pharmazie; 2008 Sep; 63(9):646-9. PubMed ID: 18819516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
